Merck & Co. Beat Expectations

Merck & Co. (MRK) reported earnings of $2.22 per share on revenue of $15.53 billion for the first quarter ended March 2025. The consensus earnings estimate was $2.15 per share on revenue of $15.53 billion. The Earnings Whisper number was $2.19 per share. The company beat expectations by 1.37% while revenue fell 1.56% compared to the same quarter a year ago.

The company said it now expects 2025 earnings of $8.82 to $8.97 per share and continues to expect revenue of $64.10 billion to $65.60 billion. The company's previous guidance was earnings of $8.88 to $9.03 per share and the current consensus earnings estimate is $8.93 per share on revenue of $64.99 billion for the year ending December 31, 2025.

Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products.